Creating impact and developing innovation in great company
Roslin Innovation Centre opened for business at the end of August 2017 and reached an occupancy of 95% in 2023, accommodated across our office and lab space.
Tenants are international in their outlook and a dynamic mix of established, local/multinational, start-up/spin out companies; social enterprise and internal University business units - each with innovation at their core.
In the early years, we were joined by tenant companies relocating from local science and research parks and companies from within the Easter Bush Campus, and many of these remain 'in residence' as they have expanded. We have continued to welcome new tenants, from within the UK and from around the globe including New Zealand, USA and Europe.
AbacusBio Ltd applies world class science and technology to improve and enhance the performance, resilience, competitiveness, responsiveness, and profitability of their clients’ enterprises.
AbacusBio is a highly respected science and technology agri-consulting company operating from offices in New Zealand, Canada and the United Kingdom to deliver world class solutions for clients across the agribusiness world.
AbacusBio moved in to our open-plan office space in August 2017 and from this UK base provide independent services and products to industry organisations, businesses, universities, and investment groups.
Benchmark Genetics is a customer focused and innovation-led company within the global aquaculture industry. It is part of the wider Benchmark Holdings group, a leader in aquaculture genetics, present in every major aquaculture market and for a wide range of species.
The company provides genetically-improved Atlantic salmon and whiteleg shrimp to global markets. Also as a leading provider of genetics services, they have extensive experience from 30 applied breeding programs involving 20 species in 16 countries and now provide the global aquaculture industry with cost-effective genotyping solutions optimised for a range of applications and species.
We welcome the Benchmark Genetics team to office and lab space at Roslin Innovation Centre.
Thomas Farrugia of Beta Bugs was announced as a Royal Society of Edinburgh (RSE) Unlocking Ambition Enterprise Fellow in June 2018 following successful completion of the Unlocking Ambition Challenge.
Beta Bugs accelerate insect evolution, creating new breeds of commercially farmed insects for the alternative protein industry and make them into next-gen crops that will drive a sustainable bio economy.
Roslin Innovation Centre is hosting the entrepreneurial start-up as part of this new programme supported by Scottish Government and RSE.
BIOCAPTIVA is a technology platform company. The company's innovative core technology, the msX™ polymer library, extracts nucleic acid (NA) directly from biological fluids, such as urine, whole blood and plasma. This is equally applicable across all mammals including humans and the extracted NAs can be used for identification of diseases, including cancer.
We welcome BIOCAPTIVA to lab and office space at Roslin Innovation Centre, providing opportunities for collaboration and access to this technology.
BioPhoundry is leveraging cutting-edge Machine Learning and Engineering Biology techniques to develop precision-engineered antibiotics aimed at addressing the global Antimicrobial Resistance (AMR) crisis.
By leveraging predictive drug design, BioPhoundry enables the precise targeting of pathogens specific to each context, minimising off-target effects and reducing the risk.
We welcome BioPhoundry to office space at Roslin Innovation Centre and increasing collaboration and knowledge sharing across the Campus and wider University in helping to address the global AMR challenge.
CanCan Diagnostics technology is aimed at supporting treatment of cancer in dogs as a monitoring tool, or to support difficult diagnoses.
We welcome Dr Parys, veterinarian at the Royal (Dick) School of Veterinary Studies and director of CanCan Diagnostics, to Roslin Innovation Centre.
Carcinotech Ltd, is a MedTech company with expertise in manufacturing 3D-printed tumours using patient-derived cancer stem cells, primary cells and established cell lines. Advanced models provide a platform for rapid, ethical, sustainable, and accurate drug discovery, screening, and pre-clinical testing.
Working with global partners, leading pharma companies, surgeons, pathologists, clinicians, and industry-leaders, the goal is to accelerate drug discovery and enable delivery of more effective cancer treatments to market.
Access to Carcinotech’s AI-driven automated manufacturing allows for accelerated production, with models offering high-throughput capabilities and provides an alternative to animal testing and an accurate precision medicine testing platform.
In March 2021, Axol Bioscience Ltd, an established provider of iPSC-derived cells, media, and characterisation services, merged with Censo Bio, a cell biology CRO with focused expertise in iPSC-related technologies. Read more
Censo Bio lease lab and office space at Roslin Innovation Centre and develop models of disease using cells from a diverse range of patients using its capabilities to generate induced Pluripotent Stem Cells (iPSCs).
The company enables the discovery and development of new targeted treatments for disease by utilising the power of stem cells; supporting global pharma and biotech industry in their search for new treatments for neurological diseases such as Alzheimer’s and Parkinson’s.
Ingenza Ltd, a spin-out from the University of Edinburgh founded in 2002, is led by a management team with over 25 years’ experience in applied bioscience and the development and commercialisation of biobased products.
Following the closure of the neighbouring Roslin BioCentre, Ingenza relocated to customised lab and office space at Roslin Innovation Centre at the end of July 2018.
The company has integrated teams of scientists, bringing together expertise across synthetic chemistry, informatics, molecular genetics, biochemistry and fermentation scale-up.
Macomics Ltd is an immuno-oncology company with world-leading expertise in macrophage biology, developing precision medicines to modulate macrophages for the treatment of cancer.
A spin-out from the University of Edinburgh, co-founded in 2020 by internationally recognised leaders in macrophage biology, Professor Jeffrey Pollard and Dr Luca Cassetta, the target discovery platform enables the identification and validation of novel macrophage therapeutic targets and is based on its deep understanding of macrophage biology.
We welcome Macomics to Roslin Innovation Centre as they expand their scientific team to support its accelerated R&D to develop a new approach to targeting the immunosuppressive tumour microenvironment, that exploits disease-specific macrophage biology to harness the power of the entire immune system.
N2 Pharmaceuticals Ltd located to Roslin Innovation Centre in December 2018.
The company has developed N2-01, a unique injectable medicine extracted from meat of Blue mussels, that has proven in laboratory settings and during its usage on animals, to reduce the level of endothelial dysfunction.
The medicine proved to be effective in numerous conditions when used on more than 25,000 companion and food producing animals by practicing veterinarians. Results of treatment improved recovery, quality of life or as a supportive treatment for cats and dogs and in dairy cattle, the treatment improved the effectiveness of artificial insemination.
N2 Pharmaceuticals is currently working on the compound's registration with the European Medical Agency. The technology has numerous patents in the UK, EU, USA and Russia.
Oxitec Ltd is building a healthy, sustainable and equitable future for humans on this planet by forging a new category of safe, sustainable, highly effective biological pest control solutions.
The company is the leading developer of biological solutions to control pests that transmit disease, destroy crops and harm livestock. The Friendly™ platform is being applied to combat the growing threat posed by disease-transmitting mosquitoes and agricultural pests that damage crops and livestock, threatening food security and livelihoods.
Oxitec is located at the Roslin Innovation Centre Agri Field Station. Work is conducted in partnership with the Roslin Institute, and focuses specifically on the world’s most devastating invasive cattle tick.
Prozymi Biolabs develops revolutionary technologies that can transform the taste and quality of gluten-free bread and baked products using naturally occurring enzymes to specifically target and degrade the toxic parts of gluten.
In 2021, the start-up company received seed funding from the University of Edinburgh Data Driven Entrepreneurship programme, while in 2022 won the Wild Card EDGE R19 in the Scottish Edge Competitions and a SMART: SCOTLAND grant from Scottish Enterprise.
We welcome the Prozymi Biolabs team to Roslin Innovation Centre, and perhaps sampling some gluten-free products baked full of flavour in a traditional way!
Roslin Technologies Ltd is an agriculture biotechnology company and focus on the development of novel agritech products as well as offering a range of commercial services, licensing and collaboration opportunities.
SeaWarm is a University of Edinburgh spin-out, from the School of Geosciences, that offers eco-friendly heating solutions. The innovative project team has developed technology to harness thermal energy from the sea that will provide sustainable heating for coastal communities and businesses.
The equipment can use sea water, rivers, ponds and even mine water to heat radiators and water for baths and showers, using the same technology as in air source heat pumps. Unlike large-scale plants, the prototypes built by the hydrogeologists are designed to be compact, easily portable for use in homes and smaller buildings, particularly in rural and coastal areas.
SeaWarm is located at the Roslin Innovation Centre Agri Field Station.
"Our new Membership packages, provides access to hot desk and meeting space at Roslin Innovation Centre and the opportunity to engage and interact with our vibrant and inspiring A3 and One Health ecosystem."
Val Hughes-White, Director of Innovation for Easter Bush CampusAlgiSys is a biotechnology company that uses microalgae to produce EPA omega-3 and plant protein ingredients, replacing fish and krill as the primary source of these nutrients.
The company uses patented and proprietary fermentation-based technology to make its products for the aquaculture, pet, animal feed, supplement, food & beverage, cosmetics, and pharmaceutical industries.
AlgiSys provides environmentally sustainable alternatives to fish and krill-based products using scalable and cost-effective production methods.
We welcome AlgiSys as a Member at Roslin Innovation Centre and look forward to facilitating introductions and potential collaborations.
The City Region Deal is a mechanism for driving productivity and accelerating growth by pulling in significant government investment in innovation, skills and infrastructure.
Easter Bush Campus is one of a network of five hubs in the Data-Driven Innovation Programme (DDI). The project will seek to leverage existing world-class research institutes and commercialisation facilities to make Easter Bush a global location of Agritech sector excellence through the deployment of a campus-wide network that will generate and collate local and global data.
Midlothian Science Zone is represented by partners from science, technology and innovation parks; research institutes; academic institutions and tenant companies located 'in the zone' with a focus on animal health, human health, aquaculture and related sectors.
This collaborative One Health community offers access to knowledge and expertise, resources and facilities, new technologies, accommodation and services, business support and networks across the Midlothian region.
A member of the Midlothian Science Zone team is generally onsite each week, based in open plan office space at Roslin Innovation Centre. Emma McCallum, was appointed project coordinator in October 2021 and is supported by Lesley Parsons who maintains the digital assets.
Please contact us if you are interested in joining us at Roslin Innovation Centre, in the heart of the University of Edinburgh's Easter Bush Campus, with laboratory and office space situated close to the science and clinical livestock expertise and providing opportunity for the natural development of business collaborators.
We have recently introduced a new Membership opportunity for Agri-Tech companies requiring touchdown space that would benefit from on-site collaboration, and we also have an off-site farm based Agri Field Station for agriculture research and development.
Whilst it's always sad to see tenants move on from Roslin Innovation Centre, we hope the time spent with us was a rewarding one and that our supportive community and flexible office and lab facilities played a part in supporting them at whatever stage they were at.
We wish all tenants the very best success for the future.